Document Type : Review Articles
Authors
1 Student Research Committee, Larestan University of Medical Sciences, Larestan, Iran
2 Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran
Abstract
Background: Cervical cancer is one of the most common female genital cancers. It accounts for about half of the one million new cases and one-quarter of all cancer deaths in women. The present study was designed to comprehensively identify the risk factors of cervical cancer using the results of similar studies.
Methods: The present study was an epidemiological review study. Searches related to the epidemiology and risk factors of cervical cancer between April 2020 and May 2020 were conducted by two researchers at four Latin scientific databases (Google Scholar, PubMed / Medline, Scopus, ISI Web of Science). The two researchers examined the extracted articles and included articles that referred to the epidemiology and risk factors of cervical cancer.
Results: The most important risk factors for cervical cancer included human papillomavirus, viral, fungal and bacterial infections, sexual behavior, smoking, pregnancy and childbirth, and other factors (family history and menopause earlier than 45 years).
Conclusion: It is recommended that health issues should be considered, especially during sexual intercourse, HPV screening in women, as well as periodic examinations for women.
Keywords
1. Mokhtari AM, Riahi S, Fathalipour M, Delam H, Hashemnejad M, Hassanipour S. The age-standardized rate of female genital cancers in Iran: a systematic review and meta-analysis. Journal of hayat. 2018;24(3):204-19.
2. Fouladseresht H, Ghorbani M, Hassanipour S, Delam H, Abdzadeh E, Mokhtari AM, Mohseni S, Riahi S, Mohammadian-Hafshejani A, Salehiniya H. The incidence of non-hodgkin lymphoma in iran: a systematic review and meta-analysis. World Cancer Research Journal. 2019;6:http-apps.
3. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020;8(2):e191-e203.
4. Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer Screening: Past, Present, and Future. Sexual Medicine Reviews. 2020;8(1):28-37.
5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.
6. Memon A, Bannister P. Epidemiology of cervical cancer. Uterine Cervical Cancer: Springer; 2019. p. 1-16.
7. Moscicki A-B, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012;30:F24-F33.
8. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives. Journal of oncology. 2019;2019.
9. Kuiava VA, Chielle EO. Epidemiology of cervix cancer in Brazil (2005-2015): study of mortality and hospital intervention rates. Archives in Biosciences & Health. 2019;1(1):45-60.
10. Weaver BA. Epidemiology and natural history of genital human papillomavirus infection. Journal of the American Osteopathic Association. 2006;106(Supplement 1):S2.
11. Burd EM. Human papillomavirus and cervical cancer. Clinical microbiology reviews. 2003;16(1):1-17.
12. Alves C, Alves L, Lunet N. Epidemiology of cervical cancer. Cancer. 2007;55:32.
13. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. American journal of public health. 2001;91(6):947.
14. Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Journal of Infectious Diseases. 2010;202(12):1789-99.
15. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. The Lancet Oncology. 2009;10(4):321.
16. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews cancer. 2002;2(5):342-50.
17. Ondrusova M, Zubor P, Ondrus D. Time trends in cervical cancer epidemiology in the Slovak Republic: reflection on the non-implementation of screening with international comparisons. Neoplasma. 2012;59(2):121-8.
18. Munoz N, Castellsagué X, de González AB, Gissmann L. HPV in the etiology of human cancer. Vaccine. 2006;24:S1-S10.
19. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999;189(1):12-9.
20. Paul SB, Tiwary BK, Choudhury AP. Studies on the Epidemiology of Cervical Cancer in Southern Assam. Assam University Journal of Science and Technology. 2011;7(1):36-42.
21. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: a meta‐analysis update. International journal of cancer. 2007;121(3):621-32.
22. Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic oncology. 2008;110(3):S4-S7.
23. Castellsagué X, Bosch FX, Muñoz N. The male role in cervical cancer. salud pública de méxico. 2003;45:345-53.
24. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Disease markers. 2007;23(4):213-27.
25. Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine. 2008;26 Suppl 12:M53-9.
26. Domingo EJ, Noviani R, Noor MRM, Ngelangel CA, Limpaphayom KK, Van Thuan T, et al. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine. 2008;26:M71-M9.
27. Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, et al. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine. 2008;26:M80-M8.
28. Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Snijders PJ, Starink TM, et al. Condom use promotes regression of human papillomavirus–associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. International Journal of Cancer. 2003;107(5):804-10.
29. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer. 1995;76(S10):1888-901.
30. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Cmaj. 2001;164(7):1017-25.
31. Louie K, De Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer C, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. British journal of cancer. 2009;100(7):1191-7.
32. Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomedical Research and Therapy. 2017;4(12):1795-811.
33. Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, et al. Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort. International journal of cancer. 2014;135(2):453-66.
34. Sugawara Y, Tsuji I, Mizoue T, Inoue M, Sawada N, Matsuo K, et al. Cigarette smoking and cervical cancer risk: An evaluation based on a systematic review and meta-analysis among Japanese women. Japanese journal of clinical oncology. 2019;49(1):77-86.
35. Brinton LA, Schairer C, Haenszel W, Stolley P, Lehman HF, Levine R, et al. Cigarette smoking and invasive cervical cancer. Jama. 1986;255(23):3265-9.
36. Schiffman MH, Haley NJ, Felton JS, Andrews A, Kaslow RA, Lancaster WD, et al. Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constitutents in the cervix. Cancer Research. 1987;47(14):3886-8.
37. Kjellberg L, Hallmans G, Åhren A, Johansson R, Bergman F, Wadell G, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. British journal of cancer. 2000;82(7):1332-8.
38. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang X, et al. Identification of benzo [a] pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer letters. 1999;146(2):127-34.
39. Domingo EJ, Echo D. Epidemiology, prevention and treatment of cervical cancer in the Philippines. Journal of gynecologic oncology. 2009;20(1):11-6.
40. Zarchi MK, Akhavan A, Gholami H, Dehghani A, Naghshi M, Mohseni F. Evaluation of cervical cancer risk-factors in women referred to Yazd-Iran hospitals from 2002 to 2009. Asian Pacific Journal of Cancer Prevention. 2010;11:537-8.
41. Brotherton JM. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine. 2008;26(2):250-6.
42. Koskela P, Anttila T, Bjørge T, Brunsvig A, Dillner J, Hakama M, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. International journal of cancer. 2000;85(1):35-9.
43. Blaise NYH, Cedric TF. Descriptive epidemiology of uterine cervix cancer at the medical oncology unit of the Yaoundé general hospital-Cameroon. GSC Biological and Pharmaceutical Sciences. 2019;9(1):083-91.
44. Hillemanns P, Soergel P, Hertel H, Jentschke M. Epidemiology and early detection of cervical cancer. Oncology research and treatment. 2016;39(9):501-6.
45. Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review. Tropical Medicine & International Health. 2009;14(10):1287-302.
46. Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and cancer. 2008;60(3):331-41.
47. Negrin LGC. Epidemiology of cervical cancer in Latin America. ecancermedicalscience. 2015;9.
48. Lacey Jr JV, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;98(4):814-21.
49. Chatterjee S, Chattopadhyay A, Samanta L. HPV and cervical cancer epidemiology-current status of HPV vaccination in India. Asian Pacific Journal of Cancer Prevention. 2016;17(8):3663-73.
)